Results(4460)
Enzalutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) in Metastatic Hormone Sensitive Prostate Cancer (mHSPC): A Non-Interventional Center-based Chart Review in Europe (ENHANCE)
France
Germany
EU PAS number:
EUPAS1000000776
First published:
24/10/2025
Study
Planned
An Observational Multi-Country Post-Authorisation Safety Study to Evaluate the Risk of Serious Adverse Cardiovascular Events in Adolescent and Adult Patients with Severe Asthma taking Tezepelumab (TRESPASS)
Denmark
France
Germany
United States
EU PAS number:
EUPAS1000000169
First published:
24/10/2025
Study
Planned
INOtuzumab Treatment Retrospective Analysis for Navigating tranSITion to CD19 CAR-T. Real-world (RWD) treatment patterns and clinical outcomes in patients with relapsed/refractory (R/R) B-cell acute lymphoblastic leukaemia (ALL) treated with inotuzumab-ozogamicin (InO) as bridge to chimeric antigen receptor T-cell (CAR-T) therapy in Spain, the United Kingdom (UK) and the United States (US) (INO-TRANSIT)
Spain
United Kingdom
United States
EU PAS number:
EUPAS1000000118
First published:
24/10/2025
Study
Ongoing
National Health Insurance Research Database
First published:
24/10/2025
Taiwan
Data source
Human
Administrative healthcare records (e.g., claims)
EAU UroEvidenceHub (UEH)
Denmark
Germany
Greece
Italy
Netherlands
Poland
Portugal
Spain
United Kingdom
First published:
24/10/2025
Network
The Danish Multiple Sclerosis Registry (DMSR), Rigshospitalet - University Hospital Copenhagen
Denmark
First published:
24/10/2025
Institution
Educational Institution
Hospital/Clinic/Other health care facility
German Atopic Dermatitis Registry TREATgermany
First published:
23/10/2025
Germany
Data source
Human
Disease registry
Primary care medical records
DARWIN EU® – Drug Utilisation Study of terbinafine-containing products
Croatia
Denmark
Finland
Germany
Spain
United Kingdom
EU PAS number:
EUPAS1000000790
First published:
23/10/2025
Study
Ongoing
Assessing the impact of remission at 12-months post-initiation of biologic therapy on long-term clinical outcomes of patients with severe asthma (SPOTLIGHT)
Argentina
Belgium
Brazil
Bulgaria
Canada
Colombia
Denmark
Estonia
Greece
India
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Norway
Poland
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS1000000789
First published:
23/10/2025
Study
Ongoing
Sustainability of response to biologics in severe asthma and predictors of late failure among patients in an international registry (SHINE)
Argentina
Belgium
Brazil
Bulgaria
Canada
Colombia
Denmark
Estonia
Greece
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Norway
Poland
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS1000000788
First published:
23/10/2025
Study
Ongoing
A Non-interventional Real-World Study on Dose Modifications of Enfortumab Vedotin (EV) in Combination with Pembrolizumab (P) in Previously Untreated Patients with Advanced Urothelial Carcinoma in Germany
Germany
EU PAS number:
EUPAS1000000467
First published:
23/10/2025
Study
Discontinued
Treatment and Clinical Characteristics in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) using Talazoparib and Enzalutamide (tala+enza) Combination Therapy
United States
EU PAS number:
EUPAS1000000580
First published:
23/10/2025
Study
Ongoing
Characterisation of complex clinical trials in the European regulatory context
Austria
Germany
Sweden
EU PAS number:
EUPAS1000000786
First published:
23/10/2025
Study
Ongoing
Prevalence and healthcare utilization of eosinophilic chronic obstructive pulmonary disease in the UK – an observational data linkage study
United Kingdom
EU PAS number:
EUPAS1000000783
First published:
23/10/2025
Study
Ongoing
Effectiveness of PCSK9 Inhibitors in Familial Hypercholesterolemia: Feasibility Analysis
Canada
EU PAS number:
EUPAS1000000387
First published:
23/10/2025
Study
Ongoing
A non-interventional post-authorisation safety study to investigate the risk of mortality in multiple sclerosis patients treated with alemtuzumab (LEMTRADA®) relative to comparable multiple sclerosis patients using other disease modifying therapies: a cohort study
Belgium
Czechia
Denmark
Germany
Sweden
United Kingdom
EU PAS number:
EUPAS42543
First published:
23/10/2025
Study
Finalised
A non-interventional post-authorisation safety study (PASS) of vortioxetine in Europe
Finland
Netherlands
Spain
EU PAS number:
EUPAS19199
First published:
23/10/2025
Study
Finalised
ERN RARE-LIVER prospective research registry
First published:
23/10/2025
Argentina
Austria
Belgium
Canada
Croatia
Czechia
Denmark
France
Germany
Greece
Hungary
Israel
Italy
Lithuania
Moldova, Republic of
Netherlands
Poland
Portugal
Romania
Slovakia
Spain
Sweden
Switzerland
United Kingdom
Data source
Human
Disease registry
Other
Princess Máxima Center for pediatric oncology
Netherlands
First published:
23/10/2025
Institution
Hospital/Clinic/Other health care facility
Laboratory/Research/Testing facility
SAFETY-VAC: Phenotype proposal and rates of immunocompromised populations in real-world data sources.
Denmark
Finland
France
Italy
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000000288
First published:
23/10/2025
Study
Planned
SAFETY-VAC: Network of Data Sources for Vaccine Safety Evaluation
Denmark
Finland
France
Italy
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000000193
First published:
23/10/2025
Study
Finalised
SAFETY-VAC: Background incidence estimation of flares of pre-existing chronic diseases using pan-European electronic healthcare data sources.
Denmark
Finland
France
Italy
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000000233
First published:
23/10/2025
Study
Ongoing
Exposure and coverage to routine schedule vaccines in different EU countries (ADVANCE-POC2)
Belgium
Denmark
Italy
Netherlands
Spain
Switzerland
United Kingdom
United States
EU PAS number:
EUPAS27851
First published:
23/10/2025
Study
Planned
EMIF Use Case 17 - Investigating the relationship in paediatric population between dosing of antibiotics (prescribed, dispensed or administered) and patient’s weight. (EMIF UC17)
Italy
Netherlands
Spain
EU PAS number:
EUPAS24458
First published:
23/10/2025
Study
Ongoing
Pedianet
First published:
23/10/2025
Italy
Data source
Human
Other
Population registry
Primary care medical records
Burden and consequences of the use of COPD-related systemic corticosteroids (OCS COPD study)
United Kingdom
EU PAS number:
EUPAS35975
First published:
20/10/2025
Study
Finalised
Understanding high-risk COPD: Analysis of real-world data to investigate characteristics and outcomes in patients with high-risk COPD. (OPRI 2306: High Risk COPD)
Australia
United Kingdom
EU PAS number:
EUPAS107087
First published:
20/10/2025
Study
Finalised
ContrAceptive Research on E4 – Health Effects on eveRyday wellbeing (CARE4HER): A post-authorisation, observational, single-arm, open-label study to evaluate health-related quality of life using the Sociedad Española de Contracepción Quality of Life Questionnaire in women prescribed estetrol (14.2 mg)/ drospirenone (3 mg) for contraception.
Germany
Hungary
Italy
Poland
EU PAS number:
EUPAS106503
First published:
20/10/2025
Study
Finalised
Population Health Data Center (PHDc), National Cheng Kung University (NCKU)
Taiwan
First published:
20/10/2025
Institution
Educational Institution
ENCePP partner
A multi-center, observational prospective post-authorization safety study to compare the cardiovascular risks and long-term safety of OZAWADE® in patients with obstructive sleep apnoea treated or not by primary therapy and exposed or not to OZAWADE® when used in routine medical practice
France
Germany
Italy
EU PAS number:
EUPAS1000000147
First published:
17/10/2025
Study
Ongoing
Extended Cohort for E-health, Environment and DNA
First published:
17/10/2025
United Kingdom
Data source
Human
Biobank
Primary care medical records
German Pharmacoepidemiological Research Database
First published:
17/10/2025
Germany
Data source
Human
Administrative healthcare records (e.g., claims)
Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care
First published:
17/10/2025
United Kingdom
Data source
Human
Disease registry
Primary care medical records
Advancing the Patient Experience in Chronic Obstructive Pulmonary Disease (COPD) Registry
First published:
17/10/2025
United States
Data source
Human
Disease registry
Other
Primary care medical records
Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension
First published:
17/10/2025
Austria
Belgium
Germany
Hungary
Italy
Latvia
Lithuania
Netherlands
Poland
Switzerland
United Kingdom
Data source
Human
Disease registry
INvestigating SIGnificant Health TrendS in Growth Hormone Treatments Registry
First published:
17/10/2025
Germany
Data source
Human
Disease registry
INvestigating SIGnificant Health TrendS in progressive fibrosing Interstitial Lung Disease
First published:
17/10/2025
Germany
Data source
Human
Disease registry
id.DRIVE pilot study to assess the detection of RSV, hMPV and PIV when using multi-specimen collection compared to a single nasopharyngeal swab
Spain
EU PAS number:
EUPAS1000000780
First published:
17/10/2025
Study
Planned